Korea Pharmaceutical and Biotechnology Association Launches Collective Learning-Based New Drug Development Project
On the 17th, the Korea Pharmaceutical and Biotechnology Association held an opening ceremony for the Association’s ‘Collective Learning-Based New Drug Development Acceleration Project Group (K-MELLODDY Project Group)’. The Korea Pharmaceutical and Biotechnology Society (Chairman Noh Yeon-hong) announced on the 17th that it is holding an opening ceremony for the ‘Learning-Based New Drug Development Acceleration Project […]
Dong-A ST Unveils Preclinical Results of SHP1 Allosteric Inhibitor and Immunotherapy Drug ‘DA-4511’ at the AACR
Dong-A ST announces preclinical results of the SHP1 allosteric inhibitor and immunotherapy drug ‘DA-4511’ at the AACR. Dong-A ST (CEO and President Kim Min-young) will present SHP1 allosteric inhibitor and immunotherapy drug ‘DA-4511’ at the ‘American Association for Cancer Research (AACR 2024)’ held in San Diego, California, USA from the 5th to the 10th. It […]
HK InnoN Celebrates 40th Anniversary with Founding Ceremony and Commitment to Compliance
HK inno.N announced on the 1st that it is holding a founding ceremony at its headquarters in Osong, Chungcheongbuk-do (located in Cheongju-si, Chungcheongbuk-do) on the 29th of last month to commemorate its 40th -year To celebrate its 40th anniversary, HK Innoen held a founding ceremony at its headquarters in Osong, Chungcheongbuk-do (located in Cheongju-si, Chungcheongbuk-do) […]
Hanmi Pharmaceutical to Unveil 10 New Research Projects at AACR 2024
Hanmi Science (hereinafter referred to as Hanmi Group), a core business company, Hanmi Pharmaceutical, will participate in the ‘American Association for Cancer Research (AACR 2024)’ held in San Diego, USA from April 5 to 10 and reveals 10 new research projects, the largest number in the industry It was announced on the 18th that it […]
Hanmi Pharmaceutical Set to Unveil 10 New Research Projects at AACR 2024
Hanmi Science (hereinafter referred to as Hanmi Group), a core business company, Hanmi Pharmaceutical, will participate in the ‘American Association for Cancer Research (AACR 2024)’ held in San Diego, USA from April 5 to 10 and reveals 10 new research projects, the largest number in the industry It was announced on the 18th that it […]
The Future of OCI and South Korean Relations with OCI
í•œë¯¸ì•½í’œê·¸ë£¹ì ˜ OCI 통합과 ê´€ë ¨í•œ 오너 ì ¼ê°€ì ˜ ê°ˆë“±ì ´ ì°¨ ì‹¬í™”ë ˜ëŠ” ì–’ìƒ ì ´ë‹¤. 한미약품그룹과 OCI 그룹간 í†µí•©ì „ 막기 위한 ì‚¬ì „ ì¡° ì¹˜ì ¸ ì‹ ì£¼ë°œí–‰ê¸ˆì§€ 가처분 ì‹ ì²ì— 대해 ì†í–‰ì ´ ê²°ì •ë 다 . ì ´ì— ëŒ€í•´ í†µí•©ì „ ë’ ê³ íŒ½íŒ½ížˆ ë§žì„œê³ ìžˆëŠ” 오너 ì ¼ê°€ëŠì„ […]
Daewoong Pharmaceutical’s Versiporosin Approved as World’s First Orphan Drug for Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical (CEO Seung-ho Jeon and Chang-jae Lee) has approved ‘Versiporosin (DWN12088),’ an idiopathic pulmonary fibrosis candidate in development as a world first new drug (first in class), as an orphan drug by the European Medicines Agency (EMA) It was announced on the 29th that it was additionally designated as. According to the company, versiporosin […]
Daewoong Pharmaceutical and KMI Sign Agreement for AI ECG Testing Solutions
Photo of the four-party MOU signed, including Daewoong Pharmaceutical and KMI, in September last year (from left, AI Medical CEO Kwon Jun-myeong, KMI Korea Medical Research Institute Chairman Lee Sang-ho , Daewoong Pharmaceutical CEO Lee Chang-jae , and Sears Technology CEO Lee Young-shin) Daewoong Pharmaceutical (CEOs Chang-jae Lee and Seung-ho Jeon) and Korea Medical Research […]
Medytox Establishes US Corporation ‘Luvantas’ for Global Market Expansion
Medytox (CEO Jeong Hyun-ho) announced on the 3rd that it has established a local US corporation, ‘Luvantas’, to advance to the global market for ‘MT10109L’, a liquid toxin preparation that does not animals that have applied for approval from the United States. FDA. ‘Ruvantas’, in which Medytox has a 100% stake, was established in Irvine, […]
Updated ADA Guidelines for Diabetes Management Reflects Research, Technology, and New Treatments
American Diabetes Association Releases Revised 2024 Diabetes Management Guidelines New Treatments and Technologies The American Diabetes Association (ADA) has announced the release of its revised 2024 diabetes management guidelines, reflecting the latest research, technology, and treatments aimed at improving the health and quality of life of diabetic patients. The new guidelines include the recommendation for […]
